Targeting epilepsy with photopharmacology in human brain tissue
Baues, M.; Elgokha, A.; Nguyen, M. M. H.; Schwering-Sohnrey, M.; Ko, T.; Schwermer, F.; Perri, F.; Opitz, T.; Kelly, T.; Huberfeld, G.; Borger, V.; Schneider, M.; Surges, R.; Beck, H.; Trauner, D.; Mueller, C. E.; Wenzel, M.
Show abstract
Photo-activatable drugs (PDs) are rapidly emerging as precision therapeutics across biomedical research, yet their potential in epilepsy treatment has remained understudied. Given that 30% of epilepsies are medically refractory, and anti-seizure medications often cause multi-organ side-effects, PDs could break new ground. Here, we evaluate light-switchable ion-channel blockers QAQ and CQAQ, and a newly developed caged propofol (CaP), in murine brain slices, and postsurgical brain tissue from patients with epilepsy or brain tumors. In mice, we show that QAQ/CQAQ reversibly suppress neuronal firing, while photo-activated CaP prolonged inhibitory post-synaptic currents and enhanced leak current. While QAQ caused identical effects in human tissue, CQAQ unexpectedly increased firing. Activated CaP robustly suppressed epileptiform activity across species. This work establishes CaP as a tool for neuroscience and disease-related studies. Our results highlight the necessity for early human model testing in biomedical research, and showcase photopharmacology as a potential powerful approach to control human epilepsy.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Development of a chemical probe to enable characterization of the casein kinase 1γ subfamily 96%
- Design and validation of the first family of photo-activatable ligands for melatonin receptors 96%
- Design of Transmembrane Mimetic Structural Probes to Trap Different Stages of γ-Secretase-Substrate Interaction 95%
Similar papers in this journal
- A genome-scale drug discovery pipeline uncovers new therapeutic targets and a unique p97 allosteric binding site in Schistosoma mansoni 96%
- Structural basis for stereospecific inhibition of ASCT2 from rational design 95%
- More than just an Eagle Killer: The freshwater cyanobacterium Aetokthonos hydrillicola produces highly toxic dolastatin derivatives 93%
Similar papers in this journal
- Potent and reversible open-channel blocker of NMDA receptor derived from dizocilpine with enhanced membrane-to-channel inhibition 94%
- Morphing Cholinesterase Inhibitor Amiridine into Multipotent Drugs for the Treatment of Alzheimer's Disease 94%
- Characterization of new highly selective pyrazolopyrimidine inhibitor of CDK7 94%
Similar papers in this journal
- Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma 97%
- Engineering of a fluorescent chemogenetic reporter with tunable color for advanced live-cell imaging 94%
- Enhancing Intracellular Accumulation and Target Engagement of PROTACs with Reversible Covalent Chemistry 94%
Similar papers in this journal
- Discovery of a new class of reversible TEA-domain transcription factor inhibitors with a novel binding mode 96%
- Stereo-specific Lasofoxifene Derivatives Reveal the Interplay between Estrogen Receptor Alpha Stability and Antagonistic Activity in ESR1 Mutant Breast Cancer Cells 95%
- Affinity-guided labeling reveals P2X7 nanoscale membrane redistribution during BV2 microglial activation 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.